This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Onishi, T. Articles by Hruska, K. Search for Related Content PubMed PubMed Citation Articles by Onishi, T. Articles by Hruska, K. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB 12-O-TETRADECANOYLPHORBOL-13-ACETATE PARATHYROID HORMONE PYRROLE

Expression of p27^Kip1 in Osteoblast-Like Cells during Differentiation with Parathyroid Hormone¹

Renal Division, Barnes-Jewish Hospital, Washington University School of Medicine, St. Louis, Missouri 63110

Address all correspondence and requests for reprints to: Keith Hruska, M.D., Renal Division, Barnes-Jewish Hospital North, 216 South Kingshighway Boulevard, St. Louis, Missouri 63110.

PTH is a major systemic regulator of bone metabolism and plays an important role in both bone formation and resorption. PTH either inhibits or stimulates osteoblastic cell proliferation depending on the model that is studied. We analyzed the cell cycle of the UMR-106 cell line, a relatively differentiated osteoblastic osteogenic sarcoma line in which PTH is known to inhibit proliferation but the mechanism of action is unknown. PTH decreased the proportion of cells in S phase and increased the number of G1 phase cells. We examined the effect of PTH on the regulators of the G1 phase cyclin-dependent kinases and found that PTH increased p27^Kip1, but not p21^Cip1, levels. This effect was mimicked by 8-bromo-cAMP, but not by phorbol 12-myristate 13-acetate. The protein kinase A inhibitor KT5720 abolished the effect of PTH on the increase in p27^Kip1 expression. PTH increased CDK2-associated p27^Kip1 without affecting the levels of CDK2. CDK2 activity was down-regulated by both PTH and 8-bromo-cAMP treatment. These data suggest that PTH blocks entry of cells into S phase and inhibits cell proliferation as the consequence of an increase in p27^Kip1, which is mediated through the protein kinase A pathway. The inhibition of G1 cyclin-dependent kinases by p27^Kip1 could cause a reduction of phosphorylation of key substrates and inactivation of transcription factors essential for entry into S phase. The inhibition of cell cycle progression through PKA-mediated p27^Kip1 induction might play an important role in PTH-induced differentiation of osteoblasts.

This article has been cited by other articles:

				Y.-H. Wang, Y. Liu, and D. W. Rowe Effects of transient PTH on early proliferation, apoptosis, and subsequent differentiation of osteoblast in primary osteoblast cultures Am J Physiol Endocrinol Metab, February 1, 2007; 292(2): E594 - E603. [Abstract] [Full Text] [PDF]

				H. W. Lee, J. H. Suh, A Y. Kim, Y. S. Lee, S. Y. Park, and J. B. Kim Histone Deacetylase 1-Mediated Histone Modification Regulates Osteoblast Differentiation Mol. Endocrinol., October 1, 2006; 20(10): 2432 - 2443. [Abstract] [Full Text] [PDF]

				L. Qin, J. Tamasi, L. Raggatt, X. Li, J. H. M. Feyen, D. C. Lee, E. DiCicco-Bloom, and N. C. Partridge Amphiregulin Is a Novel Growth Factor Involved in Normal Bone Development and in the Cellular Response to Parathyroid Hormone Stimulation J. Biol. Chem., February 4, 2005; 280(5): 3974 - 3981. [Abstract] [Full Text] [PDF]

				L. Qin, X. Li, J.-K. Ko, and N. C. Partridge Parathyroid Hormone Uses Multiple Mechanisms to Arrest the Cell Cycle Progression of Osteoblastic Cells from G1 to S Phase J. Biol. Chem., January 28, 2005; 280(4): 3104 - 3111. [Abstract] [Full Text] [PDF]

				C. Osborne, P. Wilson, and D. Tripathy Oncogenes and Tumor Suppressor Genes in Breast Cancer: Potential Diagnostic and Therapeutic Applications Oncologist, July 1, 2004; 9(4): 361 - 377. [Abstract] [Full Text] [PDF]

				A. Sunters, D. P. Thomas, W. A. Yeudall, and A. E. Grigoriadis Accelerated Cell Cycle Progression in Osteoblasts Overexpressing the c-fos Proto-oncogene: INDUCTION OF CYCLIN A AND ENHANCED CDK2 ACTIVITY J. Biol. Chem., March 12, 2004; 279(11): 9882 - 9891. [Abstract] [Full Text] [PDF]

				D. Jiang, R. T. Franceschi, H. Boules, and G. Xiao Parathyroid Hormone Induction of the Osteocalcin Gene: REQUIREMENT FOR AN OSTEOBLAST-SPECIFIC ELEMENT 1 SEQUENCE IN THE PROMOTER AND INVOLVEMENT OF MULTIPLE SIGNALING PATHWAYS J. Biol. Chem., February 13, 2004; 279(7): 5329 - 5337. [Abstract] [Full Text] [PDF]

				L. Qin, P. Qiu, L. Wang, X. Li, J. T. Swarthout, P. Soteropoulos, P. Tolias, and N. C. Partridge Gene Expression Profiles and Transcription Factors Involved in Parathyroid Hormone Signaling in Osteoblasts Revealed by Microarray and Bioinformatics J. Biol. Chem., May 23, 2003; 278(22): 19723 - 19731. [Abstract] [Full Text] [PDF]

				M. Filipits, G. Pohl, T. Stranzl, H. Kaufmann, J. Ackermann, H. Gisslinger, H. Greinix, A. Chott, and J. Drach Low p27Kip1 Expression Is an Independent Adverse Prognostic Factor in Patients with Multiple Myeloma Clin. Cancer Res., February 1, 2003; 9(2): 820 - 826. [Abstract] [Full Text] [PDF]

				M. Montcouquiol and J. T. Corwin Brief Treatments with Forskolin Enhance S-Phase Entry in Balance Epithelia from the Ears of Rats J. Neurosci., February 1, 2001; 21(3): 974 - 982. [Abstract] [Full Text] [PDF]

				C. J. Jones, D. Kipling, M. Morris, P. Hepburn, J. Skinner, A. Bounacer, F. S. Wyllie, M. Ivan, J. Bartek, D. Wynford-Thomas, et al. Evidence for a Telomere-Independent "Clock" Limiting RAS Oncogene-Driven Proliferation of Human Thyroid Epithelial Cells Mol. Cell. Biol., August 1, 2000; 20(15): 5690 - 5699. [Abstract] [Full Text]

				W. D. Stuart, S. Maeda, P. Khera, J. A. Fagin, and T. L. Clemens Parathyroid hormone-related protein induces G1 phase growth arrest of vascular smooth muscle cells Am J Physiol Endocrinol Metab, July 1, 2000; 279(1): E60 - E67. [Abstract] [Full Text] [PDF]

				P. R. Turner, S. Mefford, S. Christakos, and R. A. Nissenson Apoptosis Mediated by Activation of the G Protein-Coupled Receptor for Parathyroid Hormone (PTH)/ PTH-Related Protein (PTHrP) Mol. Endocrinol., February 1, 2000; 14(2): 241 - 254. [Abstract] [Full Text]

				R. G. Pestell, C. Albanese, A. T. Reutens, J. E. Segall, R. J. Lee, and A. Arnold The Cyclins and Cyclin-Dependent Kinase Inhibitors in Hormonal Regulation of Proliferation and Differentiation Endocr. Rev., August 1, 1999; 20(4): 501 - 534. [Abstract] [Full Text] [PDF]

				H. Drissi, D. Hushka, F. Aslam, Q. Nguyen, E. Buffone, A. Koff, A. J. van Wijnen, J. B. Lian, J. L. Stein, and G. S. Stein The Cell Cycle Regulator p27kip1 Contributes to Growth and Differentiation of Osteoblasts Cancer Res., August 1, 1999; 59(15): 3705 - 3711. [Abstract] [Full Text] [PDF]

				R. V. Lloyd, L. A. Erickson, L. Jin, E. Kulig, X. Qian, J. C. Cheville, and B. W. Scheithauer p27kip1: A Multifunctional Cyclin-Dependent Kinase Inhibitor with Prognostic Significance in Human Cancers Am. J. Pathol., February 1, 1999; 154(2): 313 - 323. [Abstract] [Full Text] [PDF]

				J. T. Swarthout, T. A. Doggett, J. L. Lemker, and N. C. Partridge Stimulation of Extracellular Signal-regulated Kinases and Proliferation in Rat Osteoblastic Cells by Parathyroid Hormone Is Protein Kinase C-dependent J. Biol. Chem., March 2, 2001; 276(10): 7586 - 7592. [Abstract] [Full Text] [PDF]